Cabot Corp CBT
We take great care to ensure that the data presented and summarized in this overview for CABOT CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CBT
View all-
Black Rock Inc. New York, NY7.22MShares$445 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.96MShares$367 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$257 Million0.06% of portfolio
-
Earnest Partners LLC Atlanta, GA3.19MShares$196 Million1.11% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA2.22MShares$137 Million0.59% of portfolio
-
State Street Corp Boston, MA2.01MShares$124 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.81MShares$111 Million0.07% of portfolio
-
Bank Of America Corp Charlotte, NC1.68MShares$104 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.56MShares$95.9 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA1.34MShares$82.5 Million0.01% of portfolio
Latest Institutional Activity in CBT
Top Purchases
Top Sells
About CBT
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Insider Transactions at CBT
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2025
|
William F Masterson Iii Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
3,486
+32.59%
|
-
|
|
Nov 19
2025
|
Sean D Keohane President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,338
-2.49%
|
$609,942
$59.76 P/Share
|
|
Nov 19
2025
|
Sean D Keohane President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
63,562
+7.39%
|
-
|
|
Nov 19
2025
|
Jeff Ji Zhu Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
998
-1.16%
|
$58,882
$59.76 P/Share
|
|
Nov 19
2025
|
Jeff Ji Zhu Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,469
+6.43%
|
-
|
|
Nov 19
2025
|
Erica Mc Laughlin Executive Vice President, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,259
-2.82%
|
$133,281
$59.76 P/Share
|
|
Nov 19
2025
|
Erica Mc Laughlin Executive Vice President, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,226
+9.08%
|
-
|
|
Nov 19
2025
|
Lisa M Dumont VP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
200
-1.68%
|
$11,800
$59.76 P/Share
|
|
Nov 19
2025
|
Lisa M Dumont VP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,507
+9.88%
|
-
|
|
Nov 19
2025
|
Karen A Kalita SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-1.89%
|
$51,448
$59.76 P/Share
|
|
Nov 19
2025
|
Karen A Kalita SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
8,602
+8.92%
|
-
|
|
Nov 19
2025
|
Matthew Forster Wood Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
219
-1.6%
|
$12,921
$59.76 P/Share
|
|
Nov 19
2025
|
Matthew Forster Wood Senior Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
671
+4.66%
|
-
|
|
Nov 11
2025
|
Erica Mc Laughlin Executive Vice President, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,253
-3.36%
|
$137,433
$61.41 P/Share
|
|
Nov 11
2025
|
Sean D Keohane President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,608
-2.93%
|
$647,088
$61.41 P/Share
|
|
Nov 11
2025
|
Jeff Ji Zhu Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,024
-1.35%
|
$62,464
$61.41 P/Share
|
|
Nov 11
2025
|
Karen A Kalita SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
895
-2.33%
|
$54,595
$61.41 P/Share
|
|
Nov 11
2025
|
Lisa M Dumont VP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
358
-3.67%
|
$21,838
$61.41 P/Share
|
|
Nov 11
2025
|
Matthew Forster Wood Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
394
-2.93%
|
$24,034
$61.41 P/Share
|
|
Aug 14
2025
|
Sean D Keohane President and CEO |
SELL
Open market or private sale
|
Direct |
114,436
-6.7%
|
$9,040,444
$79.43 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 126K shares |
|---|---|
| Exercise of conversion of derivative security | 114K shares |
| Payment of exercise price or tax liability | 30.4K shares |
|---|---|
| Open market or private sale | 114K shares |
| Bona fide gift | 1.3K shares |